| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000034813 |
| Receipt No. | R000039612 |
| Official scientific title of the study | Study on improvement of coldness by ingestion of mixed fermented tea leaf powder made from unripe orange fruits and green tea leaves (2) |
| Date of disclosure of the study information | 2018/11/22 |
| Last modified on | 2019/01/04 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Study on improvement of coldness by ingestion of mixed fermented tea leaf powder made from unripe orange fruits and green tea leaves (2) | |
| Title of the study (Brief title) | Study on improvement of coldness by ingestion of mixed fermented tea leaf powder(2) | |
| Region |
|
|
| Condition | ||
| Condition | coldness | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effects of ingestion fermented tea leaf powder on improvement of coldness |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | coldness |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | The subjects ingested the placebo meal,and ingested the active meal after 7days. | |
| Interventions/Control_2 | The subjects ingested the active meal,and ingested the placebo meal after 7days. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Healthy male and female between 20 and 70 years old
2) Individuals who has subjective symptoms of coldness 3) Individuals who can refrain from over drinking and over eating during the test period 4) Individuals who understand the purpose and contents of the experiment |
|||
| Key exclusion criteria | 1)Subjects who are contracting or treating severe kidney and/or liver diseases
2)Individuals who have a chronic diseases and regularly use drugs 3)Those who can not stop taking a large amount of green tea or black tea during the test period 4)Pregnant women, or women with intending to become pregnant, and lactating woman 5)Individuals participating or intending to participate in a drug administration test 6)Individuals whose skin surface temperature increase more than 10 degrees for 30 minutes after cooliny load in the intake of the placebo meal. 7)Individuals judged by the doctor to be unsuitable |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Kazunari Tanaka |
| Organization | Univercity of Nagasaki |
| Division name | Faculty of Nursing and Nutrition |
| Address | 1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195 |
| TEL | 095-813-5216 |
| katanaka@sun.ac.jp | |
| Public contact | |
| Name of contact person | Hideki Ito |
| Organization | Univercity of Nagasaki |
| Division name | Regional Partnership Center |
| Address | 1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195 |
| TEL | 095-813-5500 |
| Homepage URL | |
| katanaka@sun.ac.jp | |
| Sponsor | |
| Institute | Univercity of Nagasaki |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Bio-oriented Technology Research Advancement Institution,NARO |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039612 |